REG – Optima Health PLC – Result of Annual General Meeting
OPT
RNS Number : 8460V Optima Health PLC 22 September 2026
Optima Health plc
(“Optima”, the “Company”, and, together with its subsidiaries, the “Group”)
Result of Annual General Meeting
LONDON, UK, 22 September 2026, Optima Health (AIM: OPT), the UK’s leading provider of technology enabled corporate health and wellbeing solutions, today announces that all proposed resolutions were duly passed at its Annual General Meeting (“AGM”), held at 12pm BST, today 22 September
The full proxy results of the AGM meeting will shortly be provided in the Investor Relations section of the Company’s website at www.optimahealth.co.uk
Enquiries
Optima Health Jonathan Thomas, CEO Andrew Bones, Interim CFO | +44(0) 33 0008 5113 media@OptimaHealth.co.uk |
Nominated Adviser and Joint Corporate Broker Panmure Liberum Limited Emma Earl / Will Goode/ Mark Rogers / Rupert Dearden | +44 (0)20 3100 2000 |
Joint Corporate Broker Cavendish Capital Markets Geoff Nash / Ben Jeynes / George Lawson / Julian Morse / Michael Johnson/ Nigel Birks | + 44 (0)20 7220 0500 |
UK Financial PR Adviser ICR Healthcare Mary-Jane Elliott / Chris Welsh / Lindsey Neville | optimahealth@icrinc.com |
About Optima Health
Optima Health is the UK’s leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. Following completion of the acquisition of PAM Healthcare Limited in March 2026, the enlarged Group employs more than 1,250 clinicians directly, supported by a wider network of more than 1,000 subcontracted associate clinicians, and delivers more than one million interventions each year across a national network of clinics.
In addition to its core UK market, Optima Health operates in the Republic of Ireland through Optima Health Ireland and Corporate Health Ireland (CHI), where the Group is now market leader, as well as in the UK
For more information visit www.optimahealth.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END RAGLTMITMTTTBAF
Read the full articleCreate a free account to access this article and thousands more published daily.
